Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$1.08 - $2.08 $201,197 - $387,491
-186,294 Reduced 43.31%
243,877 $507,000
Q3 2023

Nov 14, 2023

BUY
$1.57 - $2.54 $5,276 - $8,536
3,361 Added 0.79%
430,171 $714,000
Q2 2023

Aug 11, 2023

BUY
$2.21 - $5.75 $364,230 - $947,657
164,810 Added 62.9%
426,810 $1.01 Million
Q1 2023

May 12, 2023

SELL
$1.72 - $3.53 $45,580 - $93,545
-26,500 Reduced 9.19%
262,000 $925,000
Q4 2022

Feb 13, 2023

BUY
$1.54 - $2.74 $37,576 - $66,856
24,400 Added 9.24%
288,500 $470,000
Q3 2022

Nov 14, 2022

BUY
$1.55 - $2.48 $167,555 - $268,088
108,100 Added 69.29%
264,100 $516,000
Q2 2022

Aug 12, 2022

BUY
$1.71 - $3.26 $49,590 - $94,540
29,000 Added 22.83%
156,000 $304,000
Q1 2022

May 13, 2022

BUY
$2.66 - $3.99 $11,970 - $17,955
4,500 Added 3.67%
127,000 $387,000
Q4 2021

Feb 11, 2022

SELL
$3.5 - $6.58 $263,550 - $495,474
-75,300 Reduced 38.07%
122,500 $490,000
Q3 2021

Nov 12, 2021

BUY
$3.97 - $5.64 $193,148 - $274,397
48,652 Added 32.62%
197,800 $969,000
Q2 2021

Aug 13, 2021

SELL
$4.36 - $5.75 $107,482 - $141,749
-24,652 Reduced 14.18%
149,148 $740,000
Q1 2021

May 13, 2021

BUY
$5.11 - $7.41 $674,009 - $977,379
131,900 Added 314.8%
173,800 $888,000
Q4 2020

Feb 10, 2021

SELL
$3.11 - $6.06 $171,983 - $335,118
-55,300 Reduced 56.89%
41,900 $254,000
Q3 2020

Nov 13, 2020

BUY
$2.61 - $5.1 $199,404 - $389,640
76,400 Added 367.31%
97,200 $303,000
Q2 2020

Aug 13, 2020

BUY
$2.6 - $3.81 $54,080 - $79,248
20,800 New
20,800 $59,000

Others Institutions Holding EYEN

About EYENOVIA, INC.


  • Ticker EYEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,212,900
  • Market Cap $3.42M
  • Description
  • Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the develop...
More about EYEN
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.